RO7504109: Immune Cell Study

We are investigating how the new treatment RO7504109 affects immune cells in healthy individuals. This research may help us learn more about its potential uses in the future.

6-12 months Safety phase (I)AllergologyDermatologyInternal MedicineOphthalmologyOtolaryngologyPediatricsPsychiatry

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre for Human Drug Research

Immunology

Oegstgeest, Netherlands

Sponsor: F. Hoffmann-La Roche AG

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.